Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Sells MassArray Instrument to Roswell Park Cancer Institute

NEW YORK, May 20 (GenomeWeb News) - Sequenom has sold a MassArray genotyping instrument to the Roswell Park Cancer Institute, the San Diego-based company said today.

 

The institute, based in Buffalo, NY, will initially use the system for pharmacogenomic studies in breast cancer patients to predict response to treatment, as well as to determine who is at risk for cardiovascular disese.

 

Sequenom's MassArray system analyzes DNA by mass spectrometry.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.